Thomas Moyer, Mayo Clinic, Department of Laboratory Medicine and Pathology, describes the four basic categories of patients as identified through a sensitive genotype test, and how the doses of the blood-thinner warfarin would typically be adjusted to reflect differences in patients’ metabolism of warfarin and also their sensitivity, to prevent stroke or hospitalisation due to excessive bleeding.
Most read
Features
Profiles
